|
ATE264833T1
(de)
|
1996-01-16 |
2004-05-15 |
Bristol Myers Squibb Co |
Konformationseingeschränkte aromatische inhibitoren des microsomalen triglyceridtransferproteins und verfahren
|
|
US20040006011A1
(en)
*
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
US5760246A
(en)
*
|
1996-12-17 |
1998-06-02 |
Biller; Scott A. |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
DE60040676D1
(de)
|
1999-09-17 |
2008-12-11 |
Millennium Pharm Inc |
BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
|
|
AU2001231154A1
(en)
|
2000-01-24 |
2001-07-31 |
Adherex Technologies Inc. |
Peptidomimetic modulators of cell adhesion
|
|
AU2001234689A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
Bivalent phenylene inhibitors of factor xa
|
|
US6403588B1
(en)
*
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
AU2001252609A1
(en)
|
2000-04-27 |
2001-11-12 |
Imperial Cancer Research Technology Ltd. |
Imidazopyridine derivatives
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
AU2002214626A1
(en)
|
2000-09-29 |
2002-04-08 |
Cor Therapeutics, Inc. |
Quaternary amines and related inhibitors of factor xa
|
|
AU2001295992A1
(en)
|
2000-10-24 |
2002-05-06 |
Sankyo Company Limited |
Imidazopyridine derivatives
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
US7129242B2
(en)
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0100569D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
New compounds
|
|
BR0207096A
(pt)
|
2001-02-20 |
2004-01-20 |
Astrazeneca Ab |
Uso de um composto, compostos, formulação farmacêutica, e, método de tratamento e/ou profilaxia de condições associadas com a inibição de glicogênio sintase quinase-3
|
|
EP1383799A4
(en)
|
2001-04-10 |
2008-08-06 |
Transtech Pharma Inc |
PROBES, SYSTEMS AND METHODS FOR DISCOVERING MEDICAMENTS
|
|
HUP0400266A2
(hu)
|
2001-06-21 |
2004-08-30 |
Smithkline Beecham Corp. |
Imidazo[1,2-a]piridin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk herpeszvírus-fertőzések megelőzésére vagy kezelésére
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
EP1270551A1
(en)
|
2001-06-26 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Urea derivatives with antiproteolytic activity
|
|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
WO2003031446A1
(en)
|
2001-10-05 |
2003-04-17 |
Smithkline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
|
DE60225316T2
(de)
|
2001-11-13 |
2009-02-26 |
AXYS Pharmaceuticals, Inc., South San Francisco |
Cyanoalkylamino-derivate als protease-hemmer
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
GB0212049D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2388358A1
(en)
|
2002-05-31 |
2003-11-30 |
Voiceage Corporation |
A method and device for multi-rate lattice vector quantization
|
|
JP3725105B2
(ja)
*
|
2002-08-30 |
2005-12-07 |
株式会社東芝 |
二次電池の過放電防止回路及び二次電池の過放電防止法
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
EP1551795A1
(en)
|
2002-10-17 |
2005-07-13 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
US20040087642A1
(en)
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
|
US20040092568A1
(en)
|
2002-10-31 |
2004-05-13 |
Zeldis Jerome B. |
Methods for the treatment, prevention and management of macular degeneration
|
|
KR20050084027A
(ko)
|
2002-11-28 |
2005-08-26 |
쉐링 악티엔게젤샤프트 |
Ｃｈｋ-, ｐｄｋ- 및 ａｋｔ-억제성 피리미딘, 그의제조방법 및 약제로서의 그의 용도
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
TW200418806A
(en)
*
|
2003-01-13 |
2004-10-01 |
Fujisawa Pharmaceutical Co |
HDAC inhibitor
|
|
TW200424174A
(en)
|
2003-02-06 |
2004-11-16 |
Hoffmann La Roche |
New TP diamide
|
|
US7208491B2
(en)
|
2003-02-07 |
2007-04-24 |
Hoffmann-La Roche Inc. |
N-monoacylated o-phenylenediamines
|
|
WO2004076452A1
(en)
|
2003-02-26 |
2004-09-10 |
Merck Sharp & Dohme Limited |
5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
EP1603900A4
(en)
|
2003-03-06 |
2008-08-20 |
Merck & Co Inc |
IMIDAZOPYRIDIN COMPOUNDS WITH EFFECT AGAINST PROTOZOEN
|
|
PL1611088T3
(pl)
|
2003-04-07 |
2009-11-30 |
Pharmacyclics Inc |
Hydroksamiany jako środki terapeutyczne
|
|
US20050187266A1
(en)
|
2003-04-15 |
2005-08-25 |
Pfizer Inc |
Alpha substituted carboxylic acids
|
|
EA200501462A1
(ru)
|
2003-04-15 |
2006-04-28 |
Пфайзер Инк. |
Альфа-замещенные карбоновые кислоты в качестве модуляторов ppar
|
|
US20050234066A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Agouron Pharmaceuticals, Inc. |
Alpha substituted carboxylic acids
|
|
EP1628666B1
(en)
|
2003-05-14 |
2015-09-23 |
NeuroGenetic Pharmaceuticals, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2005006945A2
(en)
|
2003-07-03 |
2005-01-27 |
The Salk Institute For Biological Studies |
Methods for treating neural disorders and compounds useful therefor
|
|
CA2539117A1
(en)
|
2003-09-24 |
2005-04-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
CA2744997A1
(en)
|
2003-09-26 |
2005-04-07 |
Exelixis, Inc. |
C-met modulators and method of use
|
|
KR20060124610A
(ko)
|
2003-11-06 |
2006-12-05 |
셀진 코포레이션 |
석면-관련된 질환 또는 장애를 치료 및 관리하기 위하여ｊｎｋ 억제제를 사용하는 방법 및 이 물질을 포함하는조성물
|
|
US7524851B2
(en)
|
2003-12-05 |
2009-04-28 |
Robert Bosch Gesellschaft Fur Medizinische Forschung (Rbmf) |
Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy
|
|
US7429590B2
(en)
|
2003-12-10 |
2008-09-30 |
Merck & Co. Inc. |
Antiprotozoal imidazopyridine compounds
|
|
US7671181B2
(en)
|
2004-01-16 |
2010-03-02 |
Merck Sharp & Dohme Corp. |
Polynucleotides encoding coccidian parasite casein kinase I, a chemotherapeutic target for antiprotozoal agents
|
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20070093492A1
(en)
*
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
US7253204B2
(en)
*
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP1735319B1
(en)
*
|
2004-03-26 |
2017-05-03 |
MethylGene Inc. |
Inhibitors of histone deacetylase
|
|
MXPA06012130A
(es)
|
2004-04-20 |
2007-01-31 |
Transtech Pharma Inc |
Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
|
|
WO2005102318A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating hiv related diseases
|
|
WO2005102325A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating inflammatory muscle disorders including myositis and muscular dystrophy
|
|
WO2005102326A2
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating renal diseases
|
|
EP1758654A1
(en)
|
2004-04-23 |
2007-03-07 |
AB Science |
Use of c-kit inhibitors for treating plasmodium related diseases
|
|
CA2564574A1
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating fibrosis
|
|
BRPI0511267A
(pt)
*
|
2004-05-17 |
2007-11-27 |
Tibotec Pharm Ltd |
1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
|
|
US20070249628A1
(en)
|
2004-05-18 |
2007-10-25 |
Alain Moussy |
Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological Weapons
|
|
WO2005115304A2
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating fibrodysplasia
|
|
WO2005115385A1
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating acne
|
|
PL1781639T3
(pl)
|
2004-07-28 |
2012-07-31 |
Janssen Pharmaceutica Nv |
Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
AU2005295734A1
(en)
|
2004-10-15 |
2006-04-27 |
Biogen Idec Ma Inc. |
Methods of treating vascular injuries
|
|
CA2588558A1
(en)
|
2004-11-23 |
2006-06-01 |
Celgene Corporation |
Jnk inhibitors for treatment of cns injury
|
|
CA2588517A1
(en)
|
2004-12-01 |
2006-06-08 |
Devgen N.V. |
5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
|
|
US20090099160A1
(en)
|
2004-12-17 |
2009-04-16 |
David Andrews |
4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
|
|
WO2006070943A1
(ja)
|
2004-12-28 |
2006-07-06 |
Takeda Pharmaceutical Company Limited |
縮合イミダゾール化合物およびその用途
|
|
WO2006077401A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Pyrrolopyridines useful in the treatment of inflammation
|
|
AU2006223508A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Merck Frosst Canada Ltd |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
JP2008537748A
(ja)
|
2005-04-06 |
2008-09-25 |
エクセリクシス、インコーポレイテッド |
ｃ−Ｍｅｔモジュレーター及び使用方法
|
|
SG159561A1
(en)
|
2005-05-09 |
2010-03-30 |
Achillion Pharmaceuticals Inc |
Thiazole compounds and methods of use
|
|
JP4528918B2
(ja)
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
MA28394B1
(fr)
*
|
2005-06-24 |
2007-01-02 |
Genelabs Tech Inc |
Derives d'heteroaryle pour traitement des virus
|
|
US7309787B2
(en)
|
2005-07-13 |
2007-12-18 |
Allergan, Inc. |
Kinase inhibitors
|
|
EP1904065A2
(en)
|
2005-07-14 |
2008-04-02 |
AB Science |
Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
|
|
US20100069387A1
(en)
|
2005-09-07 |
2010-03-18 |
Palmer Stephen S |
IKK Inhibitors for the Treatment of Endometriosis
|
|
WO2007037187A1
(ja)
|
2005-09-27 |
2007-04-05 |
Shionogi & Co., Ltd. |
Ｐｇｄ２受容体アンタゴニスト活性を有するスルホンアミド誘導体
|
|
WO2007036732A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
|
AR058073A1
(es)
|
2005-10-03 |
2008-01-23 |
Astrazeneca Ab |
Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos
|
|
ITMI20060296A1
(it)
|
2006-02-17 |
2007-08-18 |
Alberto Lodolo |
Dispositivo di intercettazione multifunzionale
|
|
EP1996233A2
(en)
|
2006-02-27 |
2008-12-03 |
Gilead Colorado, Inc. |
Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
|
|
CA2649861A1
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
EP2170882A1
(en)
*
|
2007-06-26 |
2010-04-07 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
NZ602832A
(en)
*
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
|
AU2009271003A1
(en)
*
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors
|
|
AU2009276699A1
(en)
|
2008-07-28 |
2010-02-04 |
Gilead Sciences, Inc. |
Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
|
|
KR20120031170A
(ko)
*
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
|
|
ES2463826T3
(es)
*
|
2009-06-08 |
2014-05-29 |
Gilead Sciences, Inc. |
Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
|